Scientific publications

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism. A cohort study. Scientific Publication

Nov 18, 2024 | Magazine: European Journal of Endocrinology

Marta Araujo-Castro  1 , Miguel Paja Fano  2 , Marga González-Boillos  3 , Eider Pascual-Corrales  1 , Paola Parra Ramírez  4 , Patricia Martín Rojas-Marcos  4 , Ana García-Cano  5 , Jorge Gabriel Ruiz-Sanchez  6 , Almudena Vicente  7 , Emilia Gómez-Hoyos  8 , Ana Casterás  9 , Albert Puig-Perez  9 , Iñigo García Sanz  10 , Mònica Recasens  11 , Rebeca Barahona San Millan  11 , María José Picón César  12 , Patricia Díaz Guardiola  13 , Carolina Perdomo  14 , Laura Manjón-Miguélez  15 , Ángel Rebollo Román  16 , Cristina Robles Lázaro  17 , José María Recio  17 , Manuel Morales-Ruiz  18 , María Calatayud  19 , Noemi Jiménez López  19 , Diego Meneses  6 , Miguel Sampedro Nuñez  20 , Elena Mena Ribas  21 , Alicia Sanmartín Sánchez  21 , Cesar Gonzalvo Diaz  22 , Cristina Lamas  22 , María Del Castillo Tous  23 , Joaquín Serrano  24 , Theodora Michalopoulou  25 , Susana Tenes Rodrigo  26 , Ricardo Roa Chamorro  27 , Fernando Jaén Aguila  27 , Eva María Moya Mateo  28 , Sonsoles Gutiérrez-Medina  29 , Felicia Alexandra Hanzu  30


Aim: To evaluate the influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism (PA).

Methods: Multicenter retrospective study of patients with PA in 36 Spanish tertiary hospitals with available information on smoking habits (smokers and non-smokers [never smokers and ex-smokers]).

Results: A total of 881 patients were included, of whom 180 (20.4%) were classified as smokers and 701 as non-smokers. At diagnosis, smokers and non-smokers did not differ in blood pressure or serum potassium levels between. However, smokers had a higher prevalence of left ventricular hypertrophy (LVH) than non-smokers (OR 2.0, 95% CI 1.23 to 3.25), and smokers were more likely to have severe LVH than non-smokers (12.5% vs. 6.6%, P=0.164). A larger mean tumor size of the adrenal nodule/s was observed in the smoking group (18.6±9.66 vs. 15.8±8.66 mm, P=0.002). In addition, the odds of mild autonomous cortisol secretion (MACS) was greater in smokers than in non-smokers (OR 2.1, 95% CI 1.14 to 4.06), but these differences disappeared when adjusted for the size of the adrenal nodule/s (adjusted OR 1.6, 95% CI 0.76 to 3.37). The rate of biochemical and hypertension cure was similar in both groups; however, hypertension cure tended to be more frequent in the non-smoker group (41.2% vs 29.9%, P=0.076).

Conclusions: Patients with PA who smoke have a higher prevalence of LVH and MACS and larger adrenal nodule/s than non-smokers. Smoking has no significant effect on the probability of hypertension response after adrenalectomy in patients with PA.

CITATION  Eur J Endocrinol. 2024 Nov 18:lvae143.  doi: 10.1093/ejendo/lvae143